3.0xx SheerVision Ultra-Light Loupes - Titanium Frame
Navigation Links
3.0xx SheerVision Ultra-Light Loupes - Titanium Frame
| Products | 3.0xx SheerVision Ultra-Light Loupes - Titanium Frame |
| Company | SheerVision |
| Item | 3.0xx SheerVision Ultra-Light Loupes - Titanium Frame |
| Features |
|
| Description | Experience the finest surgical-quality loupes available at manufacturer-direct prices. We set the standard for innovative optical design, combining superior quality with unmatched customer support. Delivering optimum performance with maximum comfort, SheerVision loupes are the clear choice for medical professionals worldwide. All SheerVision loupes come compete with clear lens covers, fully-lined case, side shields, safety strap, flip-up paddle and a lens cleaning cloth. |
| Info | SheerVision Customer Service: (877) 678-4274 |
Related medicine products :
1. 3.0xx SheerVision Ultra-Light TTL Loupes - Titanium Frame
2. 3.0xx SheerVision Ultra-Light TTL Loupes - SV Sport Frame
3. 3.0xx SheerVision Ultra-Light Loupes - SV Sport Frame
4. SheerVision Surgical Magnifying Loupes
5. SheerVision FireFly LED Light System
6. FireFly LED Light System & SheerVision 2.5x Titanium-Frame Loupe Package
7. 2.5xx SheerVision Ultra-Light Loupes - SV Sport Frame
8. 3.0x SheerVision Loupes - Titanium Frame
9. 3.0x SheerVision Loupes - SV Sport Frame
10. 3.5x SheerVision Loupes - SV Sport Frame
11. 3.5x SheerVision Loupes - Titanium Frame
Breaking Medicine News(10 mins):Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 3Health News:Physicians knowledge of childhood food allergies needs room for improvement 2Health News:Enhanced Vision Named as one of Orange County's Top Workplaces in 2009 2Health News:Memories That Make Your Heart Race Can Be Defanged 2Health News:Medtronic, Inc. Recalls Quick-Set Infusion Sets 2
[0] IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care[0] Physicians knowledge of childhood food allergies needs room for improvement[0] Enhanced Vision Named as one of Orange County's Top Workplaces in 2009[0] Memories That Make Your Heart Race Can Be Defanged[0] Medtronic, Inc. Recalls Quick-Set Infusion Sets
Other Medicine News:Health News:Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager 2Health News:Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager 3Health News:AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan 2Health News:Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare 2Health News:Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare 3Health News:Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009 2Health News:Interactive Report Maps Landscape of Technology for the Aging 2Health News:Budgetary Constraints on Health Care Facilities to Affect PACS, RIS, and CVIS Markets 2
Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew TagerAMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation PlanPrism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital HealthcareAlign Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009Interactive Report Maps Landscape of Technology for the AgingBudgetary Constraints on Health Care Facilities to Affect PACS, RIS, and CVIS Markets
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Research Compares MENOPUR 28R 29 With rFSH in GnRH Antagonist IVF Cycles 5586 1Research Compares MENOPUR 28R 29 With rFSH in GnRH Antagonist IVF Cycles 5586 2Research Compares MENOPUR 28R 29 With rFSH in GnRH Antagonist IVF Cycles 5586 3Clues to Hypertension in Kids May Be Seen in Bones 59798 1Clues to Hypertension in Kids May Be Seen in Bones 59798 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 1Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |